Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Cash from Investing Activities (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Cash from Investing Activities data on record, last reported at $34.0 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 87.3% year-over-year to $34.0 million; the TTM value through Dec 2025 reached -$862.0 million, down 2050.98%, while the annual FY2025 figure was -$862.0 million, 2050.98% down from the prior year.
  • Cash from Investing Activities reached $34.0 million in Q4 2025 per PTCT's latest filing, up from -$289.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $267.7 million in Q4 2024 and bottomed at -$422.0 million in Q2 2025.
  • Average Cash from Investing Activities over 5 years is -$24.3 million, with a median of $3.2 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 383.54% in 2024, then tumbled 578.67% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $68.3 million in 2021, then crashed by 52.49% to $32.4 million in 2022, then crashed by 391.06% to -$94.4 million in 2023, then surged by 383.54% to $267.7 million in 2024, then tumbled by 87.3% to $34.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $34.0 million in Q4 2025, -$289.6 million in Q3 2025, and -$422.0 million in Q2 2025.